BTX News and Press, Brooklyn ImmunoTherapeutics Inc. From 05/18/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s fair to say that there’s change afoot at Brooklyn Immunotherapeutics (NYSEAMERICAN: BTX ). Some folks are averse to big changes, but BTX stock holders shouldn’t be worried at all. Source:...

Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn" or the “Company”), a biopharmaceutical company currently focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders and monogen...

Brooklyn ImmunoTherapeutics (BTX) announces a publication in Breast Cancer Research that demonstrates how multiplex immunofluorescence (mIF) may be used to characterize the immunological activity of IRX-2 in early stage breast cancer.Multiplex immunofluorescence combined with hierarchical lin...

Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer and blood disorders, today announced a publication in Breast Cancer...

There seems to be a short squeeze at Brooklyn, although I’m skeptical the source is the WallStreetBets subreddit as many claim. Short squeezes rarely last long and also the company is selling shares, which is a very good scenario to take a short position through put options. ...

Brooklyn ImmunoTherapeutics (NYSEMKT: BTX) , a relative newcomer to the world of publicly traded biotech stocks, saw its shares rip higher in April by a stunning 1,230%, according to data provided by S&P Global Market Intelligence . The stock took flight last month for ...

Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders and monogenic diseases, today announced the appointm...

Esperion Therapeutics (ESPR) -32% on Q1 earnings release.Cocrystal Pharma (COCP) -27% after launches $40M stock offering.SemiLEDs (LEDS) -21%.Mercury Systems (MRCY) -18% on FQ3 earnings release.Adamis Pharmaceuticals (ADMP) -14%.Reed's (REED) -14% after...

Brooklyn ImmunoTherapeutics (NYSEMKT: BTX) was a little-known biotech trading at $4 per share last month. As of May 4, however, its share price has rocketed to $55. Brooklyn ImmunoTherapeutics is now a mid cap with a market capitalization of nearly $2.7 billion -- and growing. It ha...

Best Health Care Stocks To Buy Right Now? 4 In Focus Health care stocks have been on a tear in the stock market . No matter what’s happening elsewhere in the economy, the health care industry will likely continue to work towards improving our quality of life. With this be...